Market Opportunity SentiAR operates in medical device visualization with real time holography for interventional procedures, presenting a clear expansion opportunity for hospitals and surgical centers looking to adopt AR assisted guidance to improve precision in cardiac and vascular interventions.

Strategic Partnerships The technology originated from Washington University and has industry validation through licensing and ongoing development, suggesting it may benefit from academic hospital collaborations, pilot programs, and joint research initiatives to accelerate adoption.

Funding & Growth Recent Series A and Series B financing totaling $8.5 million indicate investor confidence and a growth runway, signaling readiness for larger pilot deployments, enterprise sales cycles, and expanded customer success efforts.

Competitive Positioning First 3D real time holography visualization for anatomy and catheter tracking places SentiAR at a differentiated niche within AR medical visualization, creating a value pitch focused on safety, precision, and reduced procedure times.

Target Accounts Medium sized medical centers or large teaching hospitals with cardiac ablation and interventional radiology programs are likely to be early adopters due to procedure complexity, existing AR interest, and potential for impactful clinical outcomes.